66 related articles for article (PubMed ID: 33068426)
1. Elimination of NF-κB signaling in Vimentin+ stromal cells attenuates tumorigenesis in a mouse model of Barrett's Esophagus.
Anand A; Fang HY; Mohammad-Shahi D; Ingermann J; Baumeister T; Strangmann J; Schmid RM; Wang TC; Quante M
Carcinogenesis; 2021 Apr; 42(3):405-413. PubMed ID: 33068426
[TBL] [Abstract][Full Text] [Related]
2. Characterizing caspase-1 involvement during esophageal disease progression.
Barber G; Anand A; Katarzyna Oficjalska ; Phelan JJ; Heeran AB; Flis E; Clarke NE; Watson JA; Strangmann J; Flood B; O'Neill H; O'Toole D; MacCarthy F; Ravi N; Reynolds JV; Kay EW; Quante M; O'Sullivan J; Creagh EM
Cancer Immunol Immunother; 2020 Dec; 69(12):2635-2649. PubMed ID: 32613271
[TBL] [Abstract][Full Text] [Related]
3. Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia.
Kong J; Sai H; Crissey MA; Jhala N; Falk GW; Ginsberg GG; Abrams JA; Nakagawa H; Wang K; Rustgi AK; Wang TC; Lynch JP
Oncotarget; 2015 Oct; 6(32):32980-3005. PubMed ID: 26460825
[TBL] [Abstract][Full Text] [Related]
4. In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms.
Laranjeira ABA; Kong T; Snyder SC; Fulbright MC; Fisher DAC; Starczynowski DT; Oh ST
Blood; 2024 Jun; 143(23):2414-2424. PubMed ID: 38457657
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction of inflammatory cytokines and tumor development.
Yoshimura A
Cancer Sci; 2006 Jun; 97(6):439-47. PubMed ID: 16734720
[TBL] [Abstract][Full Text] [Related]
6. Deamidation Shunts RelA from Mediating Inflammation to Aerobic Glycolysis.
Zhao J; Tian M; Zhang S; Delfarah A; Gao R; Rao Y; Savas AC; Lu A; Bubb L; Lei X; Moshirian R; Zhu W; Peng C; Jiang T; Chen L; Graham NA; Feng P
Cell Metab; 2020 May; 31(5):937-955.e7. PubMed ID: 32325032
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma.
Dhakras P; Uboha N; Horner V; Reinig E; Matkowskyj KA
Transl Gastroenterol Hepatol; 2020; 5():55. PubMed ID: 33073050
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory chemoprevention attenuates the phenotype in a mouse model of esophageal adenocarcinoma.
Baumeister T; Ingermann J; Marcazzan S; Fang HY; Oellinger R; Rad R; Engleitner T; Kleigrewe K; Anand A; Strangmann J; Schmid RM; Wang TC; Quante M
Carcinogenesis; 2021 Aug; 42(8):1068-1078. PubMed ID: 33878160
[TBL] [Abstract][Full Text] [Related]
9. Integration of genome-scale data identifies candidate sleep regulators.
Lee YY; Endale M; Wu G; Ruben MD; Francey LJ; Morris AR; Choo NY; Anafi RC; Smith DF; Liu AC; Hogenesch JB
Sleep; 2023 Feb; 46(2):. PubMed ID: 36462188
[TBL] [Abstract][Full Text] [Related]
10. Novel in vivo potential of trifluoperazine to ameliorate doxorubicin-induced cardiotoxicity involves suppression of NF-κB and apoptosis.
Goda AE; Elenany AM; Elsisi AE
Life Sci; 2021 Oct; 283():119849. PubMed ID: 34343539
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type.
Shen D; Chu F; Lang Y; Zheng C; Li C; Liu K; Zhu J
Clin Exp Immunol; 2021 Oct; 206(1):110-117. PubMed ID: 34118070
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of BMP2 and BMP4 Represses Barrett's Esophagus While Enhancing the Regeneration of Squamous Epithelium in Preclinical Models.
Correia ACP; Straub D; Read M; Hoefnagel SJM; Romero-Pinedo S; Abadía-Molina AC; Clemons NJ; Wang K; Calpe S; Phillips W; Krishnadath KK
Cell Mol Gastroenterol Hepatol; 2023; 15(5):1199-1217. PubMed ID: 36706916
[TBL] [Abstract][Full Text] [Related]
13. AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas.
Ghosh P; Campos VJ; Vo DT; Guccione C; Goheen-Holland V; Tindle C; Mazzini GS; He Y; Alexandrov LB; Lippman SM; Gurski RR; Das S; Yadlapati R; Curtius K; Sahoo D
JCI Insight; 2022 Sep; 7(18):. PubMed ID: 36134663
[TBL] [Abstract][Full Text] [Related]
14. A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts.
Zhang Q; Bansal A; Dunbar KB; Chang Y; Zhang J; Balaji U; Gu J; Zhang X; Podgaetz E; Pan Z; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2022 Jun; 322(6):G598-G614. PubMed ID: 35380457
[TBL] [Abstract][Full Text] [Related]
15. Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagus.
Fang HY; Stangl S; Marcazzan S; Carvalho MJB; Baumeister T; Anand A; Strangmann J; Huspenina JS; Wang TC; Schmid RM; Feith M; Friess H; Ntziachristos V; Multhoff G; Gorpas D; Quante M
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2049-2063. PubMed ID: 34882260
[TBL] [Abstract][Full Text] [Related]
16. Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.
Sachdeva UM; Shimonosono M; Flashner S; Cruz-Acuña R; Gabre JT; Nakagawa H
Cancer Lett; 2021 Jul; 509():39-52. PubMed ID: 33838281
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.
Zhang Q; Yin X; Zhang Y
Arch Med Res; 2021 Feb; 52(2):191-199. PubMed ID: 33131925
[TBL] [Abstract][Full Text] [Related]
18. Esophageal organoids: applications and future prospects.
Liu H; Wang X
J Mol Med (Berl); 2023 Aug; 101(8):931-945. PubMed ID: 37380866
[TBL] [Abstract][Full Text] [Related]
19. What is new in cancer-associated fibroblast biomarkers?
Zhao Z; Li T; Yuan Y; Zhu Y
Cell Commun Signal; 2023 May; 21(1):96. PubMed ID: 37143134
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
